Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Targeting cell autonomous fusion as a strategy to cripple tumor cell macropinocytosis and limit proliferation and dissemination

FY 2022-23

Summary
Cancer has existed for millions of years, but even after billions of dollars in research, we haven’t found a solution that affects more than 14 million lives annually. Women account for 99% of breast cancer patients, while men account for only 1%. The lack of treatment options can be accredited to the lack of knowledge of the relationship between breast cancer and the growth of cancerous cells. Many treatment options are available, like endocrine therapy, which has been proven beneficial. However, it has been observed that about 30% of hormone receptor-positive breast cancer patients develop de novo resistance to endocrine therapy, which becomes invasive. N-myristoyltransferase (NMT) is an enzyme responsible for making substrate proteins sticky, including oncoproteins. We recently demonstrated that NMT is a biomarker in primary breast cancer tissue which could predict endocrine therapy response and recurrence. My research project will focus on validating the NMT-based test for the prediction and prognosis of breast cancer and investigate the underlying mechanism of the NMT-mediated oncogene regulation in different breast cancer types, including triple-negative breast cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486312
Name
Kavianpour Ava A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting cell autonomous fusion as a strategy to cripple tumor cell macropinocytosis and limit proliferation and dissemination
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Fusion; Lipid Receptor; Macropinocytosis; Membrane Fusion; Treatment
Abstract
Cancer has existed for millions of years, but even after billions of dollars in research, we haven’t found a solution that affects more than 14 million lives annually. Women account for 99% of breast cancer patients, while men account for only 1%. The lack of treatment options can be accredited to the lack of knowledge of the relationship between breast cancer and the growth of cancerous cells. Many treatment options are available, like endocrine therapy, which has been proven beneficial. However, it has been observed that about 30% of hormone receptor-positive breast cancer patients develop de novo resistance to endocrine therapy, which becomes invasive. N-myristoyltransferase (NMT) is an enzyme responsible for making substrate proteins sticky, including oncoproteins. We recently demonstrated that NMT is a biomarker in primary breast cancer tissue which could predict endocrine therapy response and recurrence. My research project will focus on validating the NMT-based test for the prediction and prognosis of breast cancer and investigate the underlying mechanism of the NMT-mediated oncogene regulation in different breast cancer types, including triple-negative breast cancer.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kavianpour, Ava A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~